The stock of Viking Therapeutics Inc. (VKTX) has seen a -7.57% decrease in the past week, with a 6.80% gain in the past month, and a 107.28% flourish in the past quarter. The volatility ratio for the week is 8.21%, and the volatility levels for the past 30 days are at 7.49% for VKTX. The simple moving average for the past 20 days is 2.51% for VKTX’s stock, with a 156.23% simple moving average for the past 200 days.
Is It Worth Investing in Viking Therapeutics Inc. (NASDAQ: VKTX) Right Now?
The 36-month beta value for VKTX is also noteworthy at 0.66. There are mixed opinions on the stock, with 10 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
The average price estimated by analysts for VKTX is $33.00, which is $10.22 above than the current price. The public float for VKTX is 68.03M, and at present, short sellers hold a 17.04% of that float. The average trading volume of VKTX on May 24, 2023 was 4.84M shares.
VKTX) stock’s latest price update
Viking Therapeutics Inc. (NASDAQ: VKTX)’s stock price has dropped by -6.45 in relation to previous closing price of 24.35. Nevertheless, the company has seen a loss of -7.57% in its stock price over the last five trading days. Barrons Online reported on 05/19/23 that Boeing, First Solar, and Viking Therapeutics Notch Stellar Performances Over the Last Year
VKTX Trading at 25.98% from the 50-Day Moving Average
After a stumble in the market that brought VKTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -8.99% of loss for the given period.
Volatility was left at 7.49%, however, over the last 30 days, the volatility rate increased by 8.21%, as shares surge +14.59% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +116.33% upper at present.
During the last 5 trading sessions, VKTX fell by -7.57%, which changed the moving average for the period of 200-days by +564.14% in comparison to the 20-day moving average, which settled at $22.37. In addition, Viking Therapeutics Inc. saw 142.34% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at VKTX starting from Rowland Charles A Jr, who sale 40,000 shares at the price of $25.00 back on May 16. After this action, Rowland Charles A Jr now owns 30,000 shares of Viking Therapeutics Inc., valued at $1,000,000 using the latest closing price.
MACARTNEY LAWSON, the Director of Viking Therapeutics Inc., sale 16,000 shares at $24.00 during a trade that took place back on May 16, which means that MACARTNEY LAWSON is holding 47,965 shares at $384,000 based on the most recent closing price.
Stock Fundamentals for VKTX
The total capital return value is set at -40.34, while invested capital returns managed to touch -39.53. Equity return is now at value -48.50, with -43.30 for asset returns.
Based on Viking Therapeutics Inc. (VKTX), the company’s capital structure generated 1.08 points at debt to equity in total, while total debt to capital is 1.06. Total debt to assets is 0.93, with long-term debt to equity ratio resting at 0.87. Finally, the long-term debt to capital ratio is 0.86.
The liquidity ratio also appears to be rather interesting for investors as it stands at 7.61.
In summary, Viking Therapeutics Inc. (VKTX) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.